As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...